BioCentury | Mar 5, 2012
Clinical News

MuGard regulatory update

...Pharmaceuticals said China's State Food and Drug Administration (SFDA) approved a regulatory application from partner Rhei Pharmaceuticals Inc....
...cancer patients. Access said MuGard is expected to be launched in the "next couple quarters." Rhei...
...Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam from Access under a 2008 deal. Additionally, Rhei...
BioCentury | Jan 9, 2012
Finance

PDUFAs produce yawns

...up for approval in 2012. Source:BCIQ:BioCenturyOnlineIntelligence Company Product Indication Event Milestone Access Pharmaceuticals Inc. (OTCBB:ACCP)/ RHEI Pharmaceuticals Inc....
BioCentury | Jul 11, 2011
Clinical News

MuGard regulatory update

...Access Pharmaceuticals said partner Rhei Pharmaceuticals Inc. (Hong Kong, China) received an acceptance letter from China's State Food...
...Drug Administration (SFDA) for MuGard mucoadhesive oral rinse to treat and prevent oral mucositis (OM). Rhei...
...from SFDA this half. The acceptance triggered an undisclosed milestone payment from Rhei to Access. Rhei...
BioCentury | Jan 11, 2010
Finance

Approval Watch

...single injection hyaluronic acid Osteoarthritis (OA) of the knee FDA action 2H10 AP Pharma Inc. (NASDAQ:APPA)/RHEI Pharmaceuticals Inc....
BioCentury | Jan 12, 2009
Finance

2009 milestones

...OTCBB:RPBIF) 3M Rapid Detection RSV Test Detect respiratory syncytial virus (RSV) Pivotal trial data 1H09 Rhei...
BioCentury | Dec 15, 2008
Clinical News

Tibozole: Phase III started

...oral tibozole given once daily vs. Sporanox itraconazole in about 350 patients for 14 days. RHEI...
...which markets the product in Africa and Europe. J&J markets Sporanox to treat fungal infections. RHEI Pharmaceuticals Inc....
BioCentury | Oct 16, 2006
Company News

RHEI management update

RHEI Pharmaceuticals Inc. , New Haven, Conn. Business: Cancer, Cardiovascular, Neurology Hired: Timothy Kish as president and CFO, formerly president of TMK Advisors WIR Staff cancer Cardiovascular Neurology...
BioCentury | May 8, 2006
Company News

Flamel, RHEI sales and marketing update

...FLML granted RHEI exclusive marketing rights to Asacard controlled-release aspirin in China, Taiwan, Hong Kong and...
...Hong Kong and Macau. Further terms were not disclosed. Flamel Technologies S.A. (FLML), Lyon, France RHEI Pharmaceuticals Inc....
Items per page:
1 - 8 of 8
BioCentury | Mar 5, 2012
Clinical News

MuGard regulatory update

...Pharmaceuticals said China's State Food and Drug Administration (SFDA) approved a regulatory application from partner Rhei Pharmaceuticals Inc....
...cancer patients. Access said MuGard is expected to be launched in the "next couple quarters." Rhei...
...Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam from Access under a 2008 deal. Additionally, Rhei...
BioCentury | Jan 9, 2012
Finance

PDUFAs produce yawns

...up for approval in 2012. Source:BCIQ:BioCenturyOnlineIntelligence Company Product Indication Event Milestone Access Pharmaceuticals Inc. (OTCBB:ACCP)/ RHEI Pharmaceuticals Inc....
BioCentury | Jul 11, 2011
Clinical News

MuGard regulatory update

...Access Pharmaceuticals said partner Rhei Pharmaceuticals Inc. (Hong Kong, China) received an acceptance letter from China's State Food...
...Drug Administration (SFDA) for MuGard mucoadhesive oral rinse to treat and prevent oral mucositis (OM). Rhei...
...from SFDA this half. The acceptance triggered an undisclosed milestone payment from Rhei to Access. Rhei...
BioCentury | Jan 11, 2010
Finance

Approval Watch

...single injection hyaluronic acid Osteoarthritis (OA) of the knee FDA action 2H10 AP Pharma Inc. (NASDAQ:APPA)/RHEI Pharmaceuticals Inc....
BioCentury | Jan 12, 2009
Finance

2009 milestones

...OTCBB:RPBIF) 3M Rapid Detection RSV Test Detect respiratory syncytial virus (RSV) Pivotal trial data 1H09 Rhei...
BioCentury | Dec 15, 2008
Clinical News

Tibozole: Phase III started

...oral tibozole given once daily vs. Sporanox itraconazole in about 350 patients for 14 days. RHEI...
...which markets the product in Africa and Europe. J&J markets Sporanox to treat fungal infections. RHEI Pharmaceuticals Inc....
BioCentury | Oct 16, 2006
Company News

RHEI management update

RHEI Pharmaceuticals Inc. , New Haven, Conn. Business: Cancer, Cardiovascular, Neurology Hired: Timothy Kish as president and CFO, formerly president of TMK Advisors WIR Staff cancer Cardiovascular Neurology...
BioCentury | May 8, 2006
Company News

Flamel, RHEI sales and marketing update

...FLML granted RHEI exclusive marketing rights to Asacard controlled-release aspirin in China, Taiwan, Hong Kong and...
...Hong Kong and Macau. Further terms were not disclosed. Flamel Technologies S.A. (FLML), Lyon, France RHEI Pharmaceuticals Inc....
Items per page:
1 - 8 of 8